vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and DONEGAL GROUP INC (DGICA). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $236.0M, roughly 1.5× DONEGAL GROUP INC). DONEGAL GROUP INC runs the higher net margin — 4.9% vs -0.8%, a 5.7% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs -3.7%). Over the past eight quarters, AdvanSix Inc.'s revenue compounded faster (3.4% CAGR vs -2.2%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Donegal Group Inc. is a regional US insurance holding company offering personal and commercial property and casualty insurance products. It serves Mid-Atlantic, Midwest, and Southern US customers, delivering tailored coverage for individuals, families, and small to medium businesses.
ASIX vs DGICA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $236.0M |
| Net Profit | $-2.8M | $11.5M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | — |
| Net Margin | -0.8% | 4.9% |
| Revenue YoY | 9.4% | -3.7% |
| Net Profit YoY | -892.9% | -54.3% |
| EPS (diluted) | $-0.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $236.0M | ||
| Q4 25 | $359.9M | $239.8M | ||
| Q3 25 | $374.5M | $245.9M | ||
| Q2 25 | $410.0M | $247.1M | ||
| Q1 25 | $377.8M | $245.2M | ||
| Q4 24 | $329.1M | $250.0M | ||
| Q3 24 | $398.2M | $251.7M | ||
| Q2 24 | $453.5M | $246.8M |
| Q1 26 | — | $11.5M | ||
| Q4 25 | $-2.8M | $17.2M | ||
| Q3 25 | $-2.6M | $20.1M | ||
| Q2 25 | $31.4M | $16.9M | ||
| Q1 25 | $23.3M | $25.2M | ||
| Q4 24 | $352.0K | $24.0M | ||
| Q3 24 | $22.3M | $16.8M | ||
| Q2 24 | $38.9M | $4.2M |
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | -0.7% | 8.7% | ||
| Q3 25 | -0.9% | 10.2% | ||
| Q2 25 | 7.7% | 8.3% | ||
| Q1 25 | 7.7% | 12.7% | ||
| Q4 24 | -3.9% | 11.9% | ||
| Q3 24 | 7.5% | 8.1% | ||
| Q2 24 | 11.5% | 2.0% |
| Q1 26 | — | 4.9% | ||
| Q4 25 | -0.8% | 7.2% | ||
| Q3 25 | -0.7% | 8.2% | ||
| Q2 25 | 7.7% | 6.8% | ||
| Q1 25 | 6.2% | 10.3% | ||
| Q4 24 | 0.1% | 9.6% | ||
| Q3 24 | 5.6% | 6.7% | ||
| Q2 24 | 8.6% | 1.7% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.10 | — | ||
| Q2 25 | $1.15 | — | ||
| Q1 25 | $0.86 | — | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $0.82 | — | ||
| Q2 24 | $1.43 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $649.1M |
| Total Assets | $1.7B | $2.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $19.8M | — | ||
| Q3 25 | $23.7M | — | ||
| Q2 25 | $18.4M | — | ||
| Q1 25 | $8.3M | — | ||
| Q4 24 | $19.6M | — | ||
| Q3 24 | $17.3M | — | ||
| Q2 24 | $12.1M | — |
| Q1 26 | — | $649.1M | ||
| Q4 25 | $815.2M | $640.4M | ||
| Q3 25 | $818.2M | $627.4M | ||
| Q2 25 | $823.7M | $605.7M | ||
| Q1 25 | $794.4M | $584.7M | ||
| Q4 24 | $774.6M | $545.8M | ||
| Q3 24 | $766.4M | $513.4M | ||
| Q2 24 | $746.6M | $484.1M |
| Q1 26 | — | $2.4B | ||
| Q4 25 | $1.7B | $2.4B | ||
| Q3 25 | $1.7B | $2.4B | ||
| Q2 25 | $1.6B | $2.4B | ||
| Q1 25 | $1.6B | $2.4B | ||
| Q4 24 | $1.6B | $2.3B | ||
| Q3 24 | $1.5B | $2.3B | ||
| Q2 24 | $1.5B | $2.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | — |
| Free Cash FlowOCF − Capex | $36.1M | — |
| FCF MarginFCF / Revenue | 10.0% | — |
| Capex IntensityCapex / Revenue | 7.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.7M | $70.2M | ||
| Q3 25 | $26.6M | $22.4M | ||
| Q2 25 | $21.1M | $12.1M | ||
| Q1 25 | $11.4M | $25.7M | ||
| Q4 24 | $64.2M | $67.4M | ||
| Q3 24 | $57.3M | $12.7M | ||
| Q2 24 | $50.2M | $21.7M |
| Q1 26 | — | — | ||
| Q4 25 | $36.1M | — | ||
| Q3 25 | $66.0K | — | ||
| Q2 25 | $-7.2M | — | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $29.8M | — | ||
| Q3 24 | $26.8M | — | ||
| Q2 24 | $16.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | 10.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | -6.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 3.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 7.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.08× | ||
| Q3 25 | — | 1.11× | ||
| Q2 25 | 0.67× | 0.72× | ||
| Q1 25 | 0.49× | 1.02× | ||
| Q4 24 | 182.29× | 2.81× | ||
| Q3 24 | 2.57× | 0.76× | ||
| Q2 24 | 1.29× | 5.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
DGICA
Segment breakdown not available.
